PNC-27 Reconstitution Calculator
Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.
What amount do you need?
Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.
Syringe size:
Possible vial strengths:
Best Match
Good Match
Usable
Harder to Measure
Example PNC-27 Titration Schedule
| Protocol Item | Guidance |
|---|---|
| Dose | 200–500 mcg per dose |
| Cycling | Daily for 30-day cycles (or shorter), with a 30-day minimum cycle break between |
| Response-Based Adjustment | Dosing intensity/frequency depends on individual goal and response |
Possible vial strengths:
What Is It?
PNC-27
p53-derived peptide in oncology research.
Bacteriostatic Water
Sterile water containing a bacteriostatic preservative, commonly used when preparing multi-use research vials.
How To Mix PNC-27
1
CleanUse alcohol swabs to clean the tops of both vials.
2
Draw BAC WaterDraw the selected amount of bacteriostatic water.
3
Inject SlowlyAdd the liquid slowly down the side of the vial.
4
Swirl GentlyDo not shake. Swirl gently until dissolved.
5
Store ProperlyStore as directed and protect from heat and light.
Best Practices & Common Mistakes
Best Practices
- Use sterile technique.
- Protect from light and heat.
- Store refrigerated when appropriate.
- Use clean syringe-unit math before measuring.
Common Mistakes
- Confusing milligrams with milliliters.
- Choosing an option with awkward decimal units.
- Using too little liquid for very small measurements.
- Shaking the vial aggressively.
PNC-27 Storage & Handling
Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.
Frequently Asked Questions
PNC-27 is a synthetic 32-amino-acid research peptide built from a p53-derived HDM-2 binding segment linked to a membrane-penetrating sequence. It is mainly discussed in cancer-cell research because lab studies describe binding to membrane-associated HDM-2 and pore formation in certain cancer-cell models.
Yes. Unlike compounds such as AICAR, BAM-15, or SLU-PP-332, PNC-27 is genuinely a peptide. Its sequence combines a p53 12–26 region with a membrane-residency or cell-penetrating peptide segment, which is why calculator math should treat it as a peptide vial rather than a small-molecule solution.
A reconstitution calculator only converts vial amount, liquid volume, and target amount. For example, a 5 mg PNC-27 vial mixed with 2.5 mL of bacteriostatic water gives 2 mg/mL; a 250 mcg research amount would equal 0.125 mL, or about 13 units on a U-100 syringe.
No. PNC-27 is an experimental research peptide, not an approved treatment for breast cancer, prostate cancer, pancreatic cancer, or any other cancer. The cancer-related evidence is mainly mechanistic, cell-culture, and preclinical-style research, so “protocol” claims online should not be treated as oncology guidance.
The main safety issue is the gap between lab selectivity and real human safety. Pore-forming activity, tumor-marker variability, unknown biodistribution, and lack of established human dosing make PNC-27 a high-uncertainty research peptide, especially when cancer patients are searching for “protocols” or reviews.
Practical takeaway: If your real goal is weight or metabolic health, the most useful next step is discussing approved treatment options with a clinician rather than relying on an unapproved compound.
Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.